Open Payments

Cedars-Sinai Medical Center

Type
Teaching hospital
Where
LOS ANGELES, CA
Medicare CCN
050625
Received
$20,245,989 in 1,530 records, 2020 ($4,469,559 general, $15,776,429 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2020General payment309$4,469,559
2020Research payment1,221$15,776,429

By company

CompanyRecordsAmountYears
Siemens Medical Solutions USA, Inc.18$2,689,6662020
Merck Sharp & Dohme LLC223$2,597,6252020
Eli Lilly and Company11$1,483,4672020
Edwards Lifesciences Corporation61$1,107,1912020
Boston Scientific Corporation49$985,5212020
Amgen Inc.17$862,5512020
PFIZER INC.137$799,3932020
ABBVIE INC.45$538,2532020
Brahms GmbH9$516,4982020
E.R. Squibb & Sons, L.L.C.19$509,2162020
AstraZeneca Pharmaceuticals LP17$484,4292020
Abbott Laboratories66$476,3652020
Gilead Sciences, Inc.62$410,0332020
Janssen Research & Development, LLC29$378,2502020
Takeda Pharmaceuticals U.S.A., Inc.67$347,1982020
Teva Pharmaceuticals USA, Inc.1$297,1802020
Celgene Corporation6$292,1112020
Biogen, Inc.6$276,9352020
EMD Serono, Inc.14$237,0602020
Novo Nordisk Inc6$225,2592020
Cardiovascular Systems Inc.4$203,8002020
KARL STORZ Endoscopy-America93$196,0922020
SEAGEN INC.10$183,7482020
Intercept Pharmaceuticals, Inc.27$181,6622020
Exelixis Inc.34$177,5482020
Genentech, Inc.14$164,7222020
Ipsen Biopharmaceuticals, Inc6$161,9302020
Medtronic Vascular, Inc.11$158,9782020
JAZZ PHARMACEUTICALS INC.1$152,4352020
Otsuka Pharmaceutical Co., Ltd.14$116,7042020
W. L. Gore & Associates, Inc.7$111,5182020
Karyopharm Therapeutics Inc.6$109,8382020
GlaxoSmithKline, LLC.21$106,1682020
Intuitive Surgical, Inc.17$101,6382020
United Therapeutics Corporation32$98,6862020
Arthrex, Inc.10$96,8292020
Jenavalve Technology, Inc.1$95,8822020
Stryker Corporation12$93,5582020
Horizon Therapeutics plc3$93,3952020
Olympus Corporation of the Americas3$93,3002020
Acutus Medical, Inc.1$92,0002020
AstraZeneca AB1$88,8062020
Penumbra, Inc.13$77,4382020
Novartis Pharmaceuticals Corporation4$77,1102020
TransMedics, Inc.4$74,2562020
Alexion Pharmaceuticals, Inc.19$67,0992020
Regeneron Pharmaceuticals, Inc.23$66,4122020
Allergan, Inc.13$62,9902020
Veloxis Pharmaceuticals, Inc.2$62,8132020
VIVUS LLC1$61,1422020

By nature of payment

NatureRecordsAmount
Research payment1,221$15,776,429
Royalty or License11$2,587,021
Grant68$835,239
Education124$428,999
Compensation for services other than consulting, including serving as faculty or as a speaker at a v12$263,629
Space rental or facility fees (teaching hospital only)56$145,994
Consulting Fee9$91,724
Charitable Contribution6$71,670
Gift20$35,236
Honoraria1$10,000
Food and Beverage2$44

Records

DateCompanyAmountNatureFormProductStudyYear
2020-12-31Monteris Medical Corporation$47,500GrantIn-kind items and servicesNeuroblate Device, Neuroblate2020
2020-12-31Merck Sharp & Dohme LLC$39,083Research paymentIn-kind items and servicesLENVIMA Drug, ONCOLOGYA Multicenter, Open-label Phase 2 Study of Lenvatinib E7080,MK-7902 Plus Pembrolizumab MK-3475 in Previously Treated Sub2020
2020-12-31Abbott Laboratories$26,000Research paymentIn-kind items and servicesArchitect SARS-CoV-2 IgM Device, DiagnosticsPerformance Evaluation of ARCHITECT SARS-CoV-2 IgM2020
2020-12-31Intuitive Surgical, Inc.$16,840EducationIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2020
2020-12-31Stryker Corporation$12,932GiftCash or cash equivalentNONE Device, NONE2020
2020-12-31KARL STORZ Endoscopy-America$11,433EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$8,863EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$8,017EducationIn-kind items and servicesCCU,MODULAR,IMAGE1 CONNECT,US Device, VIDEOIMAGING2020
2020-12-31KARL STORZ Endoscopy-America$7,112EducationIn-kind items and servicesCCU,MODULAR,IMAGE1 CONNECT,US Device, VIDEOIMAGING2020
2020-12-31AstraZeneca Pharmaceuticals LP$7,086Research paymentIn-kind items and servicesEfficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum Resistant Ovaria2020
2020-12-31Brahms GmbH$6,000Research paymentCash or cash equivalentBRAHMS KRYPTOR compact PLUS (instrument) Device, Kryptor instrumentIdentification and Validation of a Cut-off for the Ratio of Soluble Fms-like Tyrosine Kinase-1 to Placental Growth Facto2020
2020-12-31Edwards Lifesciences Corporation$5,215Research paymentCash or cash equivalentEarly Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation (TMVI) System 2013-05C2020
2020-12-31KARL STORZ Endoscopy-America$4,918EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$4,409EducationIn-kind items and servicesCCU,MODULAR,IMAGE1 CONNECT,US Device, VIDEOIMAGING2020
2020-12-31Linvatec Corporation$3,976GrantIn-kind items and servicesFLUID MANAGEMENT/PUMPS Device, ORTHOPEDIC SURGERY2020
2020-12-31KARL STORZ Endoscopy-America$3,809EducationIn-kind items and servicesCCU,MODULAR,IMAGE1 CONNECT,US Device, VIDEOIMAGING2020
2020-12-31AstraZeneca Pharmaceuticals LP$3,233Research paymentIn-kind items and servicesFASENRA Drug, RespiratoryA Multicenter Randomized Double Blind Parallel Group Placebo Controlled Phase 3 Efficacy and Safety Study Of Benralizuma2020
2020-12-31KARL STORZ Endoscopy-America$3,172EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$3,123EducationIn-kind items and servicesPOWER LED 175 LIGHT SOURCE W/SCB Device, VIDEOIMAGING2020
2020-12-31Intuitive Surgical, Inc.$2,720EducationIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2020
2020-12-31Intuitive Surgical, Inc.$2,720EducationIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2020
2020-12-31AstraZeneca Pharmaceuticals LP$2,681Research paymentIn-kind items and servicesTAGRISSO Drug, OncologyTo assess the efficacy and safety of AZD9291 versus Placebo in patients with Epidermal Growth Factor Receptor Mutation P2020
2020-12-31KARL STORZ Endoscopy-America$2,397EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$2,332EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$2,108EducationIn-kind items and servicesCMOS VID. CHOLEDOCHOSCOPE 8.5 FR X 500MM Device, LAPAROSCOPY2020
2020-12-31Intuitive Surgical, Inc.$1,956EducationIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2020
2020-12-31KARL STORZ Endoscopy-America$1,908EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31Siemens Medical Solutions USA, Inc.$1,644Research paymentCash or cash equivalentCSMC2020MRIPR794IPR992Li2020
2020-12-31Stryker Corporation$1,540GiftCash or cash equivalentNONE Device, NONE2020
2020-12-31Intuitive Surgical, Inc.$1,521EducationIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2020
2020-12-31KARL STORZ Endoscopy-America$1,357EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31AstraZeneca Pharmaceuticals LP$1,347Research paymentIn-kind items and servicesA Biomarker-Directed Phase 2 Platform Study in Patients with Advanced Non-Small Cell Lung Cancer whose Disease has Progr2020
2020-12-31KARL STORZ Endoscopy-America$1,260EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31Siemens Medical Solutions USA, Inc.$1,238Research paymentCash or cash equivalentCSMC2019MRIPR1101IPR1102IPR1103Maya2020
2020-12-31Siemens Medical Solutions USA, Inc.$1,101Research paymentCash or cash equivalentCSMC2020MRIPR017Li2020
2020-12-31Stryker Corporation$1,020GiftCash or cash equivalentNONE Device, NONE2020
2020-12-31AstraZeneca Pharmaceuticals LP$1,016Research paymentIn-kind items and servicesThis is a randomized open label multi center global Phase III study to assess the efficacy and safety of durvalumab plus2020
2020-12-31KARL STORZ Endoscopy-America$854EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31Abbott Laboratories$750Research paymentIn-kind items and servicesArchitect SARS-CoV-2 IgM Device, DiagnosticsPerformance Evaluation of ARCHITECT SARS-CoV-2 IgM2020
2020-12-31Siemens Medical Solutions USA, Inc.$750Research paymentCash or cash equivalentCSMC2019MRIPR785Xie2020
2020-12-31KARL STORZ Endoscopy-America$704EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$703EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$628Research paymentIn-kind items and servicesSPIES-H3-KT Device, VideoImagingEfficacy of Near Infrared Incisionless Fluorescent Cholangiography (NIFC) During Laparoscopic Cholec2020
2020-12-31KARL STORZ Endoscopy-America$585EducationIn-kind items and servicesCCU,MODULAR,IMAGE1 CONNECT,US Device, VIDEOIMAGING2020
2020-12-31Masimo Corporation$585EducationIn-kind items and servicesSET and rainbow SET Device, Devices2020
2020-12-31KARL STORZ Endoscopy-America$510EducationIn-kind items and servicesCCU,MODULAR,IMAGE1 CONNECT,US Device, VIDEOIMAGING2020
2020-12-31KARL STORZ Endoscopy-America$500EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31Abbott Laboratories$495Research paymentIn-kind items and servicesArchitect SARS-CoV-2 IgM Device, DiagnosticsPerformance Evaluation of ARCHITECT SARS-CoV-2 IgM2020
2020-12-31KARL STORZ Endoscopy-America$481EducationIn-kind items and servicesCLAMPING JAW W/BALL JOINT, LRG 16.5-23MM Device, MICRO/NOTES/MILITARY2020
2020-12-31KARL STORZ Endoscopy-America$481EducationIn-kind items and servicesCLAMPING JAW W/BALL JOINT, LRG 16.5-23MM Device, MICRO/NOTES/MILITARY2020
2020-12-31KARL STORZ Endoscopy-America$443EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$360EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$352EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$333EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$260EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$259EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$236Research paymentIn-kind items and servicesC-MAC System Device, AirwayEvaluation of Utility of Bronchoscopy After Urgent Intubation2020
2020-12-31Masimo Corporation$225EducationIn-kind items and servicesPatient SafetyNet System Device, Devices2020
2020-12-31KARL STORZ Endoscopy-America$163EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$163EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31Siemens Medical Solutions USA, Inc.$162Charitable ContributionIn-kind items and services2020
2020-12-31KARL STORZ Endoscopy-America$136EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$114EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$107EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31Masimo Corporation$68EducationIn-kind items and servicesPatient SafetyNet System Device, Devices2020
2020-12-31Masimo Corporation$67EducationIn-kind items and servicesEMMA and ISA Device, Devices2020
2020-12-31KARL STORZ Endoscopy-America$61EducationIn-kind items and servicesCCU,MODULAR,IMAGE1 CONNECT,US Device, VIDEOIMAGING2020
2020-12-31KARL STORZ Endoscopy-America$54EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$48EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$44EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$42EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$39EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$29EducationIn-kind items and servicesTELESCOPE,HOPKINS II, 30, 5mm x 29cm Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$24EducationIn-kind items and servicesHOLDING SYSTEM ROTATION SOCKET ONLY Device, LAPAROSCOPY2020
2020-12-31KARL STORZ Endoscopy-America$10EducationIn-kind items and servicesCCU,MODULAR,IMAGE1 CONNECT,US Device, VIDEOIMAGING2020
2020-12-30Merck Sharp & Dohme LLC$4,927Research paymentCash or cash equivalentKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-30Daiichi Sankyo Inc.$891Research paymentCash or cash equivalentSavaysa Drug, ThrombosisENVISAGE2020
2020-12-29Karyopharm Therapeutics Inc.$365Research paymentCash or cash equivalentXPOVIO Drug, OncologyKCP-330-0202020
2020-12-28BeiGene AUS Pty Ltd$7,967Research paymentCash or cash equivalentA Phase 1/1b, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics2020
2020-12-28Merck Sharp & Dohme LLC$805Research paymentIn-kind items and servicesMK-7339 Drug, ONCOLOGYA Phase 2 Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutatio2020
2020-12-24Merck Sharp & Dohme LLC$4,614Research paymentIn-kind items and servicesLENVIMA Drug, ONCOLOGYA Multicenter, Open-label Phase 2 Study of Lenvatinib E7080,MK-7902 Plus Pembrolizumab MK-3475 in Previously Treated Sub2020
2020-12-24PFIZER INC.$47Research paymentCash or cash equivalentVYNDAQEL Drug, CARDIOVASCULARA PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND EXTENSION STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS ME2020
2020-12-23Edwards Lifesciences Corporation$63,604Research paymentCash or cash equivalentEVOQUE TR 2019-062020
2020-12-23Gilead Sciences, Inc.$11,432Research paymentCash or cash equivalentCombined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib 2020
2020-12-23Intercept Pharmaceuticals, Inc.$11,418Research paymentCash or cash equivalent10097422020
2020-12-23Edwards Lifesciences Corporation$8,613Research paymentCash or cash equivalentThe CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study (2016-05)2020
2020-12-23ABBVIE INC.$5,355Research paymentCash or cash equivalentSKYRIZI Biological, IMMUNOLOGYM16-0662020
2020-12-23Spark Therapeutics, Inc.$5,000EducationCash or cash equivalent2020
2020-12-23Gilead Sciences, Inc.$2,545Research paymentCash or cash equivalentA Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn's Disease2020
2020-12-23ABBVIE INC.$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentHUMIRA Biological, IMMUNOLOGY2020
2020-12-23Edwards Lifesciences Corporation$1,994Research paymentCash or cash equivalentCLASP IIF (2018-07)2020
2020-12-23PFIZER INC.$1,835Research paymentCash or cash equivalentXTANDI Drug, ONCOLOGYA PHASE 3 RANDOMIZED EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE PLUS LEUPROLIDE ENZALUTAMIDE MONOTHERAPY AND PLACEBO PLUS2020
2020-12-23Gilead Sciences, Inc.$1,808Research paymentCash or cash equivalentA Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis2020
2020-12-23Edwards Lifesciences Corporation$832Research paymentCash or cash equivalentEarly Feasibility Study of the Edwards Tricuspid Transcatheter Repair System (2014-04)2020
2020-12-22Genentech, Inc.$6,368Research paymentCash or cash equivalentNon-Covered Product Drug, NoneTENECTEPLASE IN STROKE PATIENTS BETWEEN 4 5 AND 24 HOURS2020
2020-12-22Smith+Nephew, Inc.$5,920GiftIn-kind items and servicesAMBIENT SUPER TURBOVAC Device, Sports Med Access2020
2020-12-22Smith+Nephew, Inc.$2,479GiftIn-kind items and servicesHAT-TRICK Device, Extremities & Limb Restoration2020
2020-12-21Merck Sharp & Dohme LLC$19,541Research paymentIn-kind items and servicesLENVIMA Drug, ONCOLOGYA Multicenter, Open-label Phase 2 Study of Lenvatinib E7080,MK-7902 Plus Pembrolizumab MK-3475 in Previously Treated Sub2020
2020-12-21Edwards Lifesciences Corporation$7,002Research paymentCash or cash equivalentCLASP IID 2018-072020
2020-12-21Janssen Research & Development, LLC$2,498Research paymentCash or cash equivalentA Phase 1, First-in-Human, Open-Label, Dose Escalation Study of JNJ-61186372, a Human Bispecific EGFR and cMet Antibody,2020
2020-12-21Boston Scientific Corporation$2,438Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTREPRISE III2020
2020-12-21BeiGene AUS Pty Ltd$1,950Research paymentCash or cash equivalentA Phase 1/1b, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics2020
2020-12-18MERZ NORTH AMERICA, INC.$30,000Charitable ContributionCash or cash equivalent2020
2020-12-18PFIZER INC.$600Research paymentCash or cash equivalentIBRANCE Drug, ONCOLOGYPALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI2020
2020-12-18PFIZER INC.$600Research paymentCash or cash equivalentIBRANCE Drug, ONCOLOGYPALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI2020
2020-12-18PFIZER INC.$600Research paymentCash or cash equivalentIBRANCE Drug, ONCOLOGYPALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI2020
2020-12-18PFIZER INC.$600Research paymentCash or cash equivalentIBRANCE Drug, ONCOLOGYPALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI2020
2020-12-18Janssen Research & Development, LLC$580Research paymentCash or cash equivalentA Randomized, Double-blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects with High-risk, Localized or Lo2020
2020-12-17PFIZER INC.$14,950Research paymentCash or cash equivalentA PHASE 2 RANDOMIZED DOUBLEBLIND DOUBLEDUMMY PLACEBOCONTROLLED DOSERANGING DOSEFINDING PARALLEL GROUP STUDY TO ASSESS EF2020
2020-12-17Edwards Lifesciences Corporation$7,186Research paymentCash or cash equivalentEarly-TAVR Trial #2016-072020
2020-12-17Eli Lilly and Company$5,612Research paymentIn-kind items and servicesA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MONO AND COMBINATIO2020
2020-12-17Merck Sharp & Dohme LLC$5,368Research paymentIn-kind items and servicesMK-4482 Biological, INFECTIOUS DISEASEA Phase 2,3 Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety and Pharmacokin2020
2020-12-17E.R. Squibb & Sons, L.L.C.$5,000GrantCash or cash equivalent2020
2020-12-17Exelixis Inc.$4,415Research paymentCash or cash equivalentCabozantinib Drug, OncologyStudy of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors2020
2020-12-17Otsuka Pharmaceutical Co., Ltd.$2,140Research paymentCash or cash equivalentSTUDY OF ASTX295 IN PATIENTS WITH SOLID TUMORS WITH WILD-TYPE P532020
2020-12-17Takeda Pharmaceuticals U.S.A., Inc.$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentICLUSIG Drug, ONCOLOGY2020
2020-12-17Roche Products Limited$1,278Research paymentCash or cash equivalentOCREVUS Biological, ImmunologyOBSERVATIONAL STUDY OF OCRELIZUMAB TREATED MULTIPLE SCLEROSIS PATIENTS US COMMITMENT2020
2020-12-17Roche Products Limited$1,278Research paymentCash or cash equivalentOCREVUS Biological, ImmunologyOBSERVATIONAL STUDY OF OCRELIZUMAB TREATED MULTIPLE SCLEROSIS PATIENTS US COMMITMENT2020
2020-12-17Genentech, Inc.$800Research paymentCash or cash equivalentNon-Covered Product Drug, NoneTENECTEPLASE IN STROKE PATIENTS BETWEEN 4 5 AND 24 HOURS2020
2020-12-17Abbott Laboratories$500Research paymentCash or cash equivalentMitraClip Device, VascularCardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitr2020
2020-12-16Amgen Inc.$157,797Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentEVENITY Biological, Bone Health2020
2020-12-16Horizon Therapeutics plc$62,500Research paymentCash or cash equivalent2020
2020-12-16Merck Sharp & Dohme LLC$13,027Research paymentIn-kind items and servicesLENVIMA Drug, ONCOLOGYA Multicenter, Open-label Phase 2 Study of Lenvatinib E7080,MK-7902 Plus Pembrolizumab MK-3475 in Previously Treated Sub2020
2020-12-16Merck Sharp & Dohme LLC$7,751Research paymentCash or cash equivalentKEYTRUDA Biological, ONCOLOGYA Randomized, Double-Blind, Phase 3 Study of Pemetrexed Platinum Chemotherapy with or without Pembrolizumab MK-3475 in 2020
2020-12-16Intercept Pharmaceuticals, Inc.$4,309Research paymentCash or cash equivalentOCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY10118662020
2020-12-15Exelixis Inc.$14,430Research paymentCash or cash equivalentCabozantinib Drug, OncologyStudy of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors2020
2020-12-15Cook Incorporated$5,000GrantCash or cash equivalent2020
2020-12-15GlaxoSmithKline, LLC.$1,881Research paymentCash or cash equivalentA PHASE 2, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE SAFETY AND EFF2020
2020-12-15Exelixis Inc.$1,137Research paymentCash or cash equivalentCabozantinib Drug, OncologyStudy of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors2020
2020-12-15Brahms GmbH$776Research paymentCash or cash equivalentBRAHMS KRYPTOR sFlt-1 and BRAHMS KRYPTOR compact PLUS consumables Device, Prenatal screeningIdentification and Validation of a Cut-off for the Ratio of Soluble Fms-like Tyrosine Kinase-1 to Placental Growth Facto2020
2020-12-15Exelixis Inc.$711Research paymentCash or cash equivalentCabozantinib Drug, OncologyStudy of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors2020
2020-12-15Exelixis Inc.$318Research paymentCash or cash equivalentCabozantinib Drug, OncologyStudy of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors2020
2020-12-15Exelixis Inc.$227Research paymentCash or cash equivalentCabozantinib Drug, OncologyStudy of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors2020
2020-12-15Fisher Scientific Company L.L.C.$15Research paymentIn-kind items and servicessFlt-1 Device, prenatal screeningIdentification and validation of a cut-off for the ratio of suluble Fms-like Tyrosine Kinase-1 to Placental Growth Facto2020
2020-12-14E.R. Squibb & Sons, L.L.C.$50,000Research paymentCash or cash equivalentIdentification of Profibrotic Mechanisiums elaborated by KRT5+Basal Like cells in Idiopathic pulmunary fibrosis2020
2020-12-14GlaxoSmithKline, LLC.$9,160Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-12-14Alexion Pharmaceuticals, Inc.$2,052Research paymentCash or cash equivalentSoliris Drug, ImmunologySOLIRIS (eculizumab) for the Treatment of Participants with Coronavirus Disease 2019 (COVID-19) An Expanded Access Progr2020
2020-12-14Alexion Pharmaceuticals, Inc.$1,316Research paymentCash or cash equivalentSoliris Drug, ImmunologySOLIRIS (eculizumab) for the Treatment of Participants with Coronavirus Disease 2019 (COVID-19) An Expanded Access Progr2020
2020-12-14Alexion Pharmaceuticals, Inc.$1,249Research paymentCash or cash equivalentSoliris Drug, ImmunologySOLIRIS (eculizumab) for the Treatment of Participants with Coronavirus Disease 2019 (COVID-19) An Expanded Access Progr2020
2020-12-14Alexion Pharmaceuticals, Inc.$989Research paymentCash or cash equivalentSoliris Drug, ImmunologySOLIRIS (eculizumab) for the Treatment of Participants with Coronavirus Disease 2019 (COVID-19) An Expanded Access Progr2020
2020-12-14Medtronic USA, Inc.$134Research paymentCash or cash equivalentINTERSTIM Device, Sacral Nerve StimulationELITE2020
2020-12-11Medtronic USA, Inc.$23,050Research paymentCash or cash equivalentINTERSTIM Device, Sacral Nerve StimulationELITE2020
2020-12-11Allergan, Inc.$2,000EducationCash or cash equivalentDALVANCE Drug, ANTI-INFECTIVE2020
2020-12-11Bio-Rad Laboratories, Inc.$641GiftCash or cash equivalentLiquichek Device, Controls2020
2020-12-10Edwards Lifesciences Corporation$41,369Research paymentCash or cash equivalentALTERRA Early Feasibility (2016-04)2020
2020-12-10Alexion Pharmaceuticals, Inc.$5,000GrantCash or cash equivalent2020
2020-12-10GlaxoSmithKline, LLC.$4,225Research paymentCash or cash equivalentPHASE 1/2 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMA2020
2020-12-10Regeneron Pharmaceuticals, Inc.$3,355Research paymentCash or cash equivalentAN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF EVINACUMAB IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYP2020
2020-12-10Takeda Pharmaceuticals U.S.A., Inc.$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentALUNBRIG Drug, ONCOLOGY2020
2020-12-09Amgen Inc.$29,477Research paymentCash or cash equivalentValidation of Zebra VCF Detection Algorithm2020
2020-12-09United Therapeutics Corporation$24,060Research paymentCash or cash equivalentTYVASO Drug, PAHOpen-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso2020
2020-12-09Novo Nordisk Inc$23,228Research paymentCash or cash equivalentVictoza Biological, DiabetesA phase II, randomized, double blind, placebo controlled trial of liraglutide in Parkinsons disease2020
2020-12-09Merck Sharp & Dohme LLC$20,550Research paymentCash or cash equivalentMK-4482 Biological, INFECTIOUS DISEASEA Phase 2,3 Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety and Pharmacokin2020
2020-12-09Horizon Therapeutics plc$10,973Research paymentCash or cash equivalentTEPEZZA Drug, TEPEZZAMULTICENTER, SAFETY AND EFFICACY, OPEN-LABEL EXTENSION STUDY EVALUATING TEPROTUMUMAB (HZN-001) TREATMENT IN SUBJECTS WIT2020
2020-12-09Takeda Pharmaceuticals U.S.A., Inc.$10,000GrantCash or cash equivalent2020
2020-12-09Abbott Laboratories$1,572Research paymentCash or cash equivalentTriClip Transcatheter Tricuspid Valve Repair System Device, Cardiac Arrhythmias and Heart FailureClinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal2020
2020-12-08LEICA MICROSYSTEMS INC.$200GiftCash or cash equivalentN/A Device, CANCER DIAGNOSTICS2020
2020-12-07Boston Scientific Corporation$76,395Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTACURATE IDE2020
2020-12-07Edwards Lifesciences Corporation$10,150Research paymentCash or cash equivalentPARTNER II (2010-12)2020
2020-12-07Edwards Lifesciences Corporation$7,401Research paymentCash or cash equivalentEdwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart ValvesALTERRA Early Feasibility (2016-04)2020
2020-12-07Boston Scientific Corporation$2,690Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTPINNACLE FLX2020
2020-12-07BTG International Inc.$1,000GrantCash or cash equivalentCROFAB Drug, ANTI-VENOM2020
2020-12-07Edwards Lifesciences Corporation$787Research paymentCash or cash equivalentPARTNER II (2010-12)2020
2020-12-07SANOFI US SERVICES INC.$176Research paymentCash or cash equivalentSARCLISA Biological, OncologyA Phase 1/2 Open-label, Multi-center, Safety, Preliminary Efficacy and Pharmacokinetic (PK) Study of Isatuximab (SAR65092020
2020-12-04Brahms GmbH$250,000Research paymentCash or cash equivalentBRAHMS KRYPTOR sFlt-1 and PlGF Device, Prenatal screeningIdentification and Validation of a Cut-off for the Ratio of Soluble Fms-like Tyrosine Kinase-1 to Placental Growth Facto2020
2020-12-04Merck Sharp & Dohme LLC$101Research paymentIn-kind items and servicesMK-7339 Drug, ONCOLOGYA Phase 2 Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutatio2020
2020-12-03MEDIVATION LLC.$35,754Research paymentIn-kind items and servicesXTANDI Drug, ONCOLOGYA PHASE 3 RANDOMIZED EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE PLUS LEUPROLIDE ENZALUTAMIDE MONOTHERAPY AND PLACEBO PLUS2020
2020-12-03Merck Sharp & Dohme LLC$11,902Research paymentCash or cash equivalentKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-03Takeda Pharmaceuticals U.S.A., Inc.$2,200Research paymentCash or cash equivalentENTYVIO Biological, INTERNAL MEDICINELEVERAGING SOCIAL MEDIA FOR EDUCATING PATIENTS WITH INFLAMMATORY BOWEL DISEASE2020
2020-12-03Penumbra, Inc.$195Research paymentCash or cash equivalentIndigo Device, Peripheral InterventionCHEETAH2020
2020-12-02ABBVIE INC.$9,500Research paymentCash or cash equivalentSKYRIZI Biological, IMMUNOLOGYM16-0662020
2020-12-02Arthrex, Inc.$5,668Research paymentCash or cash equivalentDISTAL EXTREMITIES INSTRUMENTS FOOT & ANKLE DYNANITE Device, DISTAL EXTREMITIESCoronal Versus Sagital Placementlof Staple in Capitolunate Fusion: A Biomechanical Study2020
2020-12-02ABBVIE INC.$4,585Research paymentCash or cash equivalentHUMIRA Biological, IMMUNOLOGYP11-2922020
2020-12-02Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-02Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-02Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-02Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-02Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-02Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-02Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-02Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-02Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-02Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-02Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-02Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-02Takeda Pharmaceuticals U.S.A., Inc.$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentNINLARO Drug, ONCOLOGY2020
2020-12-02PFIZER INC.$1,750Research paymentCash or cash equivalentIBRANCE Drug, ONCOLOGYPALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI2020
2020-12-02PFIZER INC.$1,750Research paymentCash or cash equivalentIBRANCE Drug, ONCOLOGYPALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI2020
2020-12-02PFIZER INC.$1,750Research paymentCash or cash equivalentIBRANCE Drug, ONCOLOGYPALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI2020
2020-12-02Arthrex, Inc.$1,000Research paymentCash or cash equivalentSHOULDER INSTRUMENTS ELBOWS UCL Device, SHOULDERBiomechanical Comparison of Ulnar Collateral Ligament Reconstruction with and without Internal Brace2020
2020-12-01Genentech USA, Inc.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentActivase Biological, Metabolism & Primary Care2020
2020-11-30Boehringer Ingelheim Pharma GmbH & Co.KG$3,049Research paymentIn-kind items and servicesJARDIANCE Drug, DIABETESSafety & Efficacy of Empa in patients with Acute HF2020
2020-11-29KARL STORZ Endoscopy-America$337EducationIn-kind items and servicesHANDLE, ONLY, PLASTIC W/O RATCHET Device, LAPAROSCOPY2020
2020-11-27Eli Lilly and Company$70,173Research paymentCash or cash equivalent2020
2020-11-27Edwards Lifesciences Corporation$5,642Research paymentCash or cash equivalentTrial #2017-18 ExCEED2020
2020-11-25Abbott Laboratories$13,650Research paymentCash or cash equivalentPortico Transcatheter Aortic HV Device, Cardiac Arrhythmias and Heart FailurePortico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO)2020
2020-11-25BeiGene AUS Pty Ltd$5,920Research paymentCash or cash equivalentA Phase 1/1b, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics2020
2020-11-25Merck Sharp & Dohme LLC$5,486Research paymentCash or cash equivalentKEYTRUDA Biological, ONCOLOGYA Randomized, Double-Blind, Phase 3 Study of Pemetrexed Platinum Chemotherapy with or without Pembrolizumab MK-3475 in 2020
2020-11-24Merck Sharp & Dohme LLC$8,918Research paymentCash or cash equivalentKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-11-24Bayer Healthcare Pharmaceuticals Inc.$4,500Research paymentCash or cash equivalentNon-CoveredBAY 1841788 AR/Antagonist Prostate CA Phase lll (ARAMIS)2020

The latest 200 records of 1,530.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Los Angeles CountyLos Angeles city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Los Angeles, CA, county Los Angeles County, CA, state California; placed by its city name.

MeasurePlace (city or town)
Los Angeles, CA
County
Los Angeles County, CA
State
California
Population B010033,857,2639,808,66739,287,377
Population, 2020 census P13,898,74710,014,00939,538,223
Median age B0100237.238.237.9
Under 18 B0100119.2%20.6%22.0%
65 and over B0100114.2%15.2%15.7%
Households B110011,439,0973,416,44913,548,091
Foreign born B0500235.7%33.4%27.0%
Median household income B19013$81,939$90,112$99,122
Median family income B19113$94,546$101,573$113,346
Per capita income B19301$47,685$45,792$49,513
Poverty rate B1700116.5%13.7%12.0%
Unemployment rate B230258.2%7.3%6.6%
Civilian labor force B230252,128,9185,200,65620,068,466
Mean commute (minutes) B0801330.730.428.7
Bachelor's degree or higher B1500338.5%36.0%37.1%
Housing units B250011,554,3323,650,46614,644,735
Owner-occupied B2500336.0%45.9%55.9%
Renters B2500364.0%54.1%44.1%
Median home value B25077$921,200$834,200$734,700
Median gross rent B25064$1,933$1,954$2,036
White, not Hispanic B0300228.1%24.7%33.8%
Black B030028.1%7.4%5.2%
Hispanic or Latino B0300247.2%48.4%40.2%
Asian B0300211.9%14.9%15.3%
American Indian and Alaska Native B030020.1%0.2%0.3%

Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); Unemployment rate: 5.5% in Sep 2016 to 5.1% in Sep 2026; low 3.8%, high 16.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Los Angeles, CA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.